Ono Pharma remains in five GPIF-adopted ESG equity indexes in Japan

PUBT · 2d ago
Ono Pharma remains in five GPIF-adopted ESG equity indexes in Japan
  • ONO Pharmaceutical kept its constituent status in five of six ESG equity indexes used by Japan’s GPIF for domestic allocations.
  • Selection covered broad ESG screens, climate metrics, human capital themes; included MSCI Nihonkabu ESG Select Leaders, FTSE JPX Blossom Japan.
  • Company also retained inclusion in FTSE Russell’s global FTSE4Good Index Series.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ONO Pharmaceutical Co. Ltd. published the original content used to generate this news brief on August 17, 2026, and is solely responsible for the information contained therein.